© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
November 30, 2020
If approved, the vaccine may become available to the US public as early as December 21st.
Largest study of multiple health indicators over time finds widening disparities in health by race, despite increased targeted funding.
November 29, 2020
Families of patients with Dravet syndrome and other rare epileptic burdens have lived under amplified fear this year. That is why telemedicine is a more vital tool than ever.
November 27, 2020
The first case report of COVID-19 reinfection in a patient with beta thalassemia major describes absence of symptoms and two-month interval between positive PCR tests.
November 24, 2020
About 20% of 81 positive patients experienced critical neurological complications; further, half had a pre-existing history of high blood pressure or type 2 diabetes.
November 23, 2020
To date, 3 vaccine candidates with favorable safety profiles show promise in offering protection against COVID-19.
November 22, 2020
The Regeneron monoclonal antibodies are linked to reduced risk of hospitalization or ED visit among mild-to-moderate COVID-19 cases.
An interview with a pain specialist on advancing alternative pain therapy options.
November 19, 2020
C. diff infections have decreased during the ongoing pandemic.
November 17, 2020
Raymond Douglas, MD, PhD discusses how the COVID-19 pandemic has affected his clinical practice and potentially accelerated technological innovation as a whole.